New checkpoint blockers begin human trials

J Natl Cancer Inst. 2005 Jul 20;97(14):1026-8. doi: 10.1093/jnci/dji224.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Cell Cycle / drug effects*
  • Cell Cycle Proteins / drug effects*
  • Cell Cycle Proteins / metabolism
  • Clinical Trials as Topic
  • DNA Damage / drug effects
  • DNA Repair / drug effects
  • Drugs, Investigational / adverse effects
  • Drugs, Investigational / pharmacology
  • Drugs, Investigational / therapeutic use*
  • G1 Phase / drug effects
  • G2 Phase / drug effects
  • Humans
  • Maturation-Promoting Factor / drug effects
  • Transplantation, Heterologous
  • cdc25 Phosphatases / drug effects

Substances

  • Antineoplastic Agents
  • Cell Cycle Proteins
  • Drugs, Investigational
  • Maturation-Promoting Factor
  • CDC25C protein, human
  • cdc25 Phosphatases